CTSB and neoplasm: Lang et al. (2020) reported that radiation combined with capivasertib-encapsulated cathepsin B (CTSB)-reactive NPs could significantly reduce tumor cell viability and increase the rate of apoptosis than radiation alone, or free capivasertib in OSCC cells, providing a novel strategy to improve therapeutic strategy for patients with radiation resistant.